Investigating the COVID-19 mucosal immunity of children in Indonesia

SARS-CoV-2 mucosal immunity of children in Indonesia (MICIn study)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN32891583

Enrollment

100

Registered

2020-10-02

Start date

2020-10-15

Completion date

Unknown

Last updated

2020-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (SARS-CoV-2 infection) Infections and Infestations

Interventions

All participants will receive the three-time intervention after they have given their consent/assent. The researchers will take a medical history from participants/parents/carer and physically examine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children aged under 18

Exclusion criteria

Exclusion criteria: Children without parent/legal guardian permission

Design outcomes

Primary

Measure	Time frame
Mucosal immunity of SARS-COV-2 measured using fluorescent-bead-based multiplex immunoassay at baseline, 14 and 28 days	—

Secondary

Measure	Time frame
Disease symptoms measured using physical examination and anamnesis (COVID-19-related symptoms 14 days before sample collection, contact history, and comorbidities), recorded at baseline, 14, and 28 days.	—

Countries

Indonesia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026